20 billion yuan biomedical fund launched in Chengdu

On October 23, the "Sichuan-Shanghai Collaboration, Industry-Finance Symbiosis" Sichuan Venture CapitalSIIC CapitalKanghua Biological Investment Ecosystem Conference was held in Chengdu. At the meeting, the Sichuan Zhenxing Hechuang Biomedical Fund, with a target scale of 2 billion yuan and a first close scale of 1.2 billion yuan, was officially launched. The fund is jointly promoted by Sichuan Venture Capital under Sichuan Industrial Fund and SIIC Capital under Shanghai Industrial Investment (Holdings) Co., Ltd., focusing on fields such as biological product integration, cutting-edge technology transformation, and innovative product pipelines, supporting leading enterprises in mergers and acquisitions and integration, and helping Sichuan's biomedical industry extend, supplement, and strengthen its industrial chain. At the event, the fund reached intention signings with four projects: Chengdu Xianyan Biology, Chengdu Gestalt, Sichuan Mingruijia Biology, and Shanghai Xinpu Biology.